204 related articles for article (PubMed ID: 18671457)
1. Calcium, vitamin D supplements with or without alendronate and supragingival calculus formation in osteoporotic women: a preliminary study.
Buduneli N; Saygan BH; Karaduman U; Saraç F; Karaduman M; Ayçelik N
Expert Opin Pharmacother; 2008 Aug; 9(12):2015-20. PubMed ID: 18671457
[TBL] [Abstract][Full Text] [Related]
2. The effect of menopause, hormone replacement therapy (HRT), alendronate (ALN), and calcium supplements on saliva.
Yalçin F; Gurgan S; Gurgan T
J Contemp Dent Pract; 2005 May; 6(2):10-7. PubMed ID: 15915200
[TBL] [Abstract][Full Text] [Related]
3. Dental calculus: recent insights into occurrence, formation, prevention, removal and oral health effects of supragingival and subgingival deposits.
White DJ
Eur J Oral Sci; 1997 Oct; 105(5 Pt 2):508-22. PubMed ID: 9395117
[TBL] [Abstract][Full Text] [Related]
4. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
Ringe JD; Farahmand P; Schacht E; Rozehnal A
Rheumatol Int; 2007 Mar; 27(5):425-34. PubMed ID: 17216477
[TBL] [Abstract][Full Text] [Related]
5. Calcium and vitamin D supplementation and risk of kidney stone formation in postmenopausal women.
Haghighi A; Samimagham H; Gohardehi G
Iran J Kidney Dis; 2013 May; 7(3):210-3. PubMed ID: 23689153
[TBL] [Abstract][Full Text] [Related]
6. Alendronate reduces osteoclast precursors in osteoporosis.
D'Amelio P; Grimaldi A; Cristofaro MA; Ravazzoli M; Molinatti PA; Pescarmona GP; Isaia GC
Osteoporos Int; 2010 Oct; 21(10):1741-50. PubMed ID: 19949772
[TBL] [Abstract][Full Text] [Related]
7. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D
Liao EY; Zhang ZL; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; Peng YD; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L
BMC Musculoskelet Disord; 2018 Jul; 19(1):210. PubMed ID: 29970059
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal osteoporosis treatment and risk of urinary calculus development.
Ganji MR
Iran J Kidney Dis; 2013 May; 7(3):171-4. PubMed ID: 23689144
[No Abstract] [Full Text] [Related]
9. Effect of three months' frequent use of sugar-free chewing gum with and without urea on calculus formation.
Fure S; Lingström P; Birkhed D
J Dent Res; 1998 Aug; 77(8):1630-7. PubMed ID: 9719037
[TBL] [Abstract][Full Text] [Related]
10. The effects of three silica dentifrices containing Triclosan on supragingival plaque and calculus formation and on gingivitis.
Svatun B; Sadxton CA; Huntington E; Cummins D
Int Dent J; 1993 Aug; 43(4 Suppl 1):441-52. PubMed ID: 8282427
[TBL] [Abstract][Full Text] [Related]
11. Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.
Bonnick S; Broy S; Kaiser F; Teutsch C; Rosenberg E; DeLucca P; Melton M
Curr Med Res Opin; 2007 Jun; 23(6):1341-9. PubMed ID: 17594775
[TBL] [Abstract][Full Text] [Related]
12. The release of vitamin C from chewing gum and its effects on supragingival calculus formation.
Lingström P; Fure S; Dinitzen B; Fritzne C; Klefbom C; Birkhed D
Eur J Oral Sci; 2005 Feb; 113(1):20-7. PubMed ID: 15693825
[TBL] [Abstract][Full Text] [Related]
13. Effect of alendronate and vitamin D₃ on fractional calcium absorption in a double-blind, randomized, placebo-controlled trial in postmenopausal osteoporotic women.
Shapses SA; Kendler DL; Robson R; Hansen KE; Sherrell RM; Field MP; Woolf E; Berd Y; Mantz AM; Santora AC
J Bone Miner Res; 2011 Aug; 26(8):1836-44. PubMed ID: 21448918
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D status and response to daily 400 IU vitamin D3 and weekly alendronate 70 mg in men and women with osteoporosis.
Karaplis AC; Chouha F; Djandji M; Sampalis JS; Hanley DA
Ann Pharmacother; 2011 May; 45(5):561-8. PubMed ID: 21521859
[TBL] [Abstract][Full Text] [Related]
15. Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension.
Zhang ZL; Liao EY; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; De Peng Y; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L; Santora AC
Osteoporos Int; 2015 Sep; 26(9):2365-74. PubMed ID: 25929192
[TBL] [Abstract][Full Text] [Related]
16. Effects of alendronate and hormone replacement therapy, alone and in combination, on saliva, periodontal conditions and gingival crevicular fluid matrix metalloproteinase-8 levels in women with osteoporosis.
Eviö S; Tarkkila L; Sorsa T; Furuholm J; Välimäki MJ; Ylikorkala O; Tiitinen A; Meurman JH
Oral Dis; 2006 Mar; 12(2):187-93. PubMed ID: 16476042
[TBL] [Abstract][Full Text] [Related]
17. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
18. Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent.
Cosman F; Wermers RA; Recknor C; Mauck KF; Xie L; Glass EV; Krege JH
J Clin Endocrinol Metab; 2009 Oct; 94(10):3772-80. PubMed ID: 19584192
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of alendronate plus vitamin D3 versus standard care in osteoporotic postmenopausal women with vitamin D insufficiency.
Ralston SH; Binkley N; Boonen S; Kiel DP; Reginster JY; Roux C; Chen L; Rosenberg E; Santora A;
Calcif Tissue Int; 2011 Jun; 88(6):485-94. PubMed ID: 21479913
[TBL] [Abstract][Full Text] [Related]
20. Effect of calcium and vitamin D supplementation on bone mineral density in women aged 65-71 years: a 3-year randomized population-based trial (OSTPRE-FPS).
Kärkkäinen M; Tuppurainen M; Salovaara K; Sandini L; Rikkonen T; Sirola J; Honkanen R; Jurvelin J; Alhava E; Kröger H
Osteoporos Int; 2010 Dec; 21(12):2047-55. PubMed ID: 20204604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
